Search

Author/Creator Roy, Vivek

1. A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin. Issue 8 (August 2013)

Authors:
Larsen, Jeremy T.; Hogan, William J.; Micallef, Ivana N.; Dispenzieri, Angela; Gertz, Morie A.; Inwards, David J.; Tun, Han W.; Roy, Vivek; Geyer, Susan M.; Allred, Jacob B.; Wu, Wenting; Ansell, Stephen M.; Elliott, Michelle A.; Tefferi, Ayalew; Porrata, Luis F.; Gastineau, Dennis A.; Lacy, Mart...
Journal:
Leukemia & lymphoma
Issue:
Volume 54:Issue 8(2013:Aug.)
Page Start:
1713
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis. Issue 5 (24th February 2018)

Authors:
Tefferi, Ayalew; Partain, Daniel K.; Palmer, Jeanne M.; Slack, James L.; Roy, Vivek; Hogan, William J.; Litzow, Mark L.; Ketterling, Rhett P.; Patnaik, Mrinal M.
Journal:
American journal of hematology
Issue:
Volume 93:Issue 5(2018:May)
Page Start:
649
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia. Issue 8 (22nd May 2021)

Authors:
Abeykoon, Jithma P.; Zanwar, Saurabh; Ansell, Stephen M.; Muchtar, Eli; He, Rong; Greipp, Patricia T.; King, Rebecca L.; Ailawadhi, Sikander; Paludo, Jonas; Larsen, Jeremy T.; Habermann, Thomas M.; Inwards, David; Go, Ronald S.; Thanarajasingam, Gita; Buadi, Francis; Dispenzieri, Angela; Thompson...
Journal:
American journal of hematology
Issue:
Volume 96:Issue 8(2021)
Page Start:
945
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. AT‐101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemia. (17th November 2013)

Authors:
Paulus, Aneel; Chitta, Kasyapa; Akhtar, Sharoon; Personett, David; Miller, Kena C.; Thompson, Kevin J.; Carr, Jennifer; Kumar, Shaji; Roy, Vivek; Ansell, Stephen M.; Mikhael, Joseph R.; Dispenzieri, Angela; Reeder, Craig B.; Rivera, Candido E.; Foran, James; Chanan‐Khan, Asher
Journal:
British journal of haematology
Issue:
Volume 164:Number 3(2014:Feb.)
Page Start:
352
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Awareness of myeloma care and the global impact of treatment: An international internet-based prospective study. (March 2022)

Authors:
Ailawadhi, Sikander; Swaika, Abhisek; Advani, Pooja; Hodge, David; Paulus, Aneel; Khera, Nandita; Hashmi, Shahrukh K; Alegria, Victoria R; Abdulazeez, Mays; Bodepudi, Srilekha; Jamwal, Khushi; Roy, Vivek; Sher, Taimur; Chanan-Khan, Asher; Ailawadhi, Meghna
Journal:
Journal of oncology pharmacy practice
Issue:
Volume 28:Number 2(2022)
Page Start:
425
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Bendamustine, lenalidomide, and dexamethasone (BRD) is highly effective with durable responses in relapsed multiple myeloma. Issue 12 (6th October 2015)

Authors:
Kumar, Shaji K; Krishnan, Amrita; LaPlant, Betsy; Laumann, Kristina; Roy, Vivek; Zimmerman, Todd; Gertz, Morie A; Buadi, Francis K; Stockerl Goldstein, Keith; Birgin, Ann; Fiala, Mark; Duarte, Lupe; Maharaj, Michelle; Levy, Joan; Vij, Ravi
Journal:
American journal of hematology
Issue:
Volume 90:Issue 12(2015:Dec.)
Page Start:
1106
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗